KATHERINE STAHL: Open Payments
NPI 1922600113 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 58 payments from 15 companies in 2025. Trend: 2023 $1,311 · 2024 $2,397 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $412 |
| Phathom Pharmaceuticals, Inc. | 7 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $128 |
| Intercept Pharmaceuticals, Inc. | 5 | $86 |
| Ardelyx, Inc. | 3 | $73 |
| Aimmune Therapeutics, Inc. | 3 | $67 |
| Lilly USA, LLC | 2 | $43 |
| GENZYME CORPORATION | 1 | $32 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
Products named: LINZESS, VOQUEZNA, RINVOQ, OCALIVA, ENTYVIO, IBSRELA, ZENPEP, DUPIXENT.
Industry payments across NC — which companies pay providers there.
